The fragile and limited production capacity of our 1950s egg-based technology for producing influenza vaccine and the lack of a national commitment to universal annual influenza vaccination mean that influenza epidemics will continue to present a substantial public health challenge. Dr. Michael Osterholm asks, So how can we prepare?
No takes yet. Share an insight, caveat, or question.
Michael T. Osterholm (2005) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: